Literature DB >> 12738090

Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat.

Ali M Sharifi1, Radbod Darabi, Nasrin Akbarloo.   

Abstract

This study sought to examine the antihypertensive mechanism of garlic in two-kidney-one-clip (2K1C) hypertensive rat. In this study, the effect of garlic on serum and tissue including: aorta, heart, kidney, lung as well as circulatory (serum) ACE activity in 2K1C rats were examined. Four groups of rats were selected: control "CTL", sham-operated "SHAM", hypertensive "H" and garlic-treated hypertensive "GT" group. Hypertension was induced by surgery. Four weeks post-clipping, single daily dose of 50mg of aqueous extract of garlic was given orally to "GT" rats for 4 weeks. Blood pressure was measured by tail-cuff method. ACE activity was determined using HPLC. The systolic blood pressure (SBP) was significantly increased in "H" compared to "CTL" group. In "GT" group, blood pressure was significantly decreased compared to "H" group. The ACE activity in all tissues of "H" group was significantly increased compared to controls which was significantly decreased in garlic-treated compared to non-treated hypertensive rats. These results indicated a negative correlation between consumption of garlic, blood pressure and ACE activity in serum and different tissues in 2K1C rats, suggesting that garlic has a significant blood pressure lowering effect, which could partly be mediated by reduction in ACE activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738090     DOI: 10.1016/s0378-8741(03)00080-1

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  17 in total

Review 1.  A review on the effects of Allium sativum (Garlic) in metabolic syndrome.

Authors:  A Hosseini; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2015-06-03       Impact factor: 4.256

2.  Hydrogen sulfide inhibits plasma renin activity.

Authors:  Ming Lu; Yi-Hong Liu; Hong Swen Goh; Josh Jia Xing Wang; Qian-Chen Yong; Rui Wang; Jin-Song Bian
Journal:  J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 10.121

Review 3.  Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Authors:  Chaula K Vora; George A Mansoor
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

4.  A review of studies of garlic (Allium sativum) on serum lipids and blood pressure before and after 1994: does the amount of allicin released from garlic powder tablets play a role?

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2005

5.  Effect of garlic on blood pressure: a meta-analysis.

Authors:  Hai-Peng Wang; Jing Yang; Li-Qiang Qin; Xiang-Jun Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-05       Impact factor: 3.738

6.  Garlic Oil Alleviates MAPKs- and IL-6-mediated Diabetes-related Cardiac Hypertrophy in STZ-induced DM Rats.

Authors:  Sheng-Huang Chang; Chung-Jung Liu; Chia-Hua Kuo; Hong Chen; Wen-Yuan Lin; Kun-Yu Teng; Sheng-Wei Chang; Chang-Hai Tsai; Fuu-Jen Tsai; Chih-Yang Huang; Bor-Show Tzang; Wei-Wen Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-15       Impact factor: 2.629

7.  Hydroalcoholic extract of Allium eriophyllum leaves attenuates cardiac impairment in rats with simultaneous type 2 diabetes and renal hypertension.

Authors:  Z Janahmadi; A A Nekooeian; M Mozafari
Journal:  Res Pharm Sci       Date:  2015 Mar-Apr

8.  Evaluation of polyherbal formulation (SJT-HT-03) for antihypertensive activity in albino rats.

Authors:  Hardik S Ghelani; Bipin M Patel; Rina H Gokani; Manish A Rachchh
Journal:  Ayu       Date:  2014 Oct-Dec

Review 9.  Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance.

Authors:  Karin Ried; Peter Fakler
Journal:  Integr Blood Press Control       Date:  2014-12-09

Review 10.  Effect of garlic on blood pressure: a systematic review and meta-analysis.

Authors:  Karin Ried; Oliver R Frank; Nigel P Stocks; Peter Fakler; Thomas Sullivan
Journal:  BMC Cardiovasc Disord       Date:  2008-06-16       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.